VEGFA and Cirrhosis: In conclusion, YGJ and iYGJ had anti-angiogenic effects in a CCl4-induced cirrhosis mouse model and how this occurred is likely through improvement of hepatic hypoxia and inhibition of the HIF-1α/VEGF signaling pathway.